Swarm Oncology Ltd. and Cellex Cell Professionals GmbH Announce Strategic Partnership to Advance Swarm's Innovative T Cell Therapies for Solid Cancers

Contributed by: PR Newswire

Images

PR Newswire associated0

PR Newswire associated1

Tags

Cellex-Partnership

More Like This

SmartCella obtains approval for GMP manufacturing and quality control testing of cell therapies

Senior life science and medical specialists join SmartCella's Board of Directors

T-cell therapy developer, Cbio A/S Unveils 2023 Annual Report Amid Clinical Trial Preparations, Signaling Major Shift to Clinical Stage with DKK40M Financing Secured

Mestag Therapeutics Enlists Leading Cancer Biology and Immunology Advisors to Support Clinical Development of its Lead Oncology Program

Cellares Announces Expanded Agreement with Bristol Myers Squibb to Include Second CAR-T Program in Cellares’ Technology Adoption Partnership Program

How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options

SmartCella raises EUR 50 million to accelerate growth and commercialization

*For research purposes only. Anticipated visual image of LiCellGrow. All features subject to change. (Graphic: Business Wire)

PHC and CCRM Collaborate to Develop Primary T-Cell Expansion Culture Processes to Enhance Efficiency and Improve Cell Quality